Delphia (USA) Inc. - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 57 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Delphia (USA) Inc. ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$54,568
+33.1%
17,717
+12.1%
0.07%
+139.3%
Q2 2022$41,000
-77.5%
15,799
-61.2%
0.03%
-79.4%
Q1 2022$182,00040,7330.14%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$10,454,0001.67%
Boxer Capital, LLC 1,251,055$12,536,0000.44%
Pentwater Capital Management LP 4,967,227$49,772,0000.41%
KNOTT DAVID M 29,566$296,0000.10%
Perceptive Advisors 1,575,490$15,786,0000.10%
Virtus ETF Advisers LLC 24,287$243,0000.10%
Advisory Services Network, LLC 256,772$2,573,0000.08%
J. Goldman & Co LP 202,501$2,029,0000.08%
Ikarian Capital, LLC 85,837$861,0000.07%
Regent Investment Management LLC 25,000$251,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders